Ticker: NEO

Company Overview NeoGenomics, Inc. (NASDAQ: NEO) is a leading provider of oncology diagnostic testing and consultative services. The company operates multiple laboratories across the U.S. and U.K., focused on improving patient care through advanced testing technologies. Income Statement Highlight...